JZJinku Zhang

Jinku Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinku Zhang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Jirui Sun

    Department of Pathology, Baoding First Central Hospital, Baoding 071000, Hebei, China; Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, China

    7 shared publications
  • Qiushuang Ma

    Department of Pathology, Baoding First Central Hospital, Baoding 071000, Hebei, China; Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, China

    6 shared publications
  • Bingjuan Zhou

    Department of Pathology, Baoding First Central Hospital, Baoding 071000, Hebei, China; Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, China

    4 shared publications
  • Haizhi Qiao

    4 shared publications
  • Wenming Zhao

    Department of Pathology, Baoding First Central Hospital, Baoding 071000, Hebei, China; Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, China

    4 shared publications
  • Jinmei Li

    Department of Pathology, Baoding First Central Hospital, Baoding 071000, Hebei, China; Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, China

    3 shared publications

Latest Publications

  • Open Access

    Application and Practice of the Ladder Teaching System Based on Standardized Sampling in Pathological Residency Standardized Training

    by Qiushuang Ma, Bingjuan Zhou, Yingying Lan, Jirui Sun, Bingxin Zhang, Jinmei Li, Wenming Zhao, Jinku Zhang

    Pathological specimen sampling is the primary and key link of pathological diagnosis, as well as the most core and basic fundamental skill in the standardized training of resident pathologists. The standardization of sampling directly determines the quality of pathological sections, the accuracy of diagnosis, and the construction of trainees’ clinical pathological thinking. At present, most resident trainees have common problems such as weak sampling concepts, non-standard operations, insufficient lesion identification, and sampling omissions, which constitute the main bottleneck restricting the quality of pathological residency training. Based on the growth law of pathological talents, the Pathology Residency Training Base of Baoding First Central Hospital integrates standardized sampling teaching into the whole three-year residency training, and constructs a characteristic sampling training system of “admission desensitization–ladder-based practical operation–subspecialty competency–quality control review–closed-loop improvement” to target and solve trainees’ problems including weak foundation, random operation and unclear key points. This paper focuses on expounding the core value of standardized sampling in consolidating the foundation of pathological residency training, and summarizes the base’s hierarchical sampling training mode, quality control management measures and practical effects, so as to provide a promotable practical scheme for domestic pathological residency training bases to strengthen basic teaching and improve trainees’ core professional competencies.

  • Open Access

    Application of Electronic Pathology Reading Library in Standardized Practical Skill Training of Clinical Pathology Residents

    by Qiushuang Ma, Bingjuan Zhou, Ying Chang, Minghan Yang, Ling Yin, Jinku Zhang

    Objective: To enhance the reading skills of clinical pathology residents, it is essential to establish a well-structured electronic pathology reading library. Methods: In accordance with the Resident Standardization Training Content and Standards (2022 Edition), clinical pathology residents are required to master pathological diagnoses across 11 systems: skin, head and neck, mediastinum and respiratory, digestive, urinary and male reproductive, female reproductive and breast, lymphatic and hematopoietic, bone and soft tissue, cardiovascular, central nervous, and endocrine diseases. Senior pathologists specializing in each subspecialty selected classic pathological slides, which were systematically scanned and compiled into an electronic pathology library. Results: A questionnaire survey was conducted to gather feedback on the electronic pathology reading library. Residents generally found it to be convenient, efficient, and conducive to learning. Conclusion: Training in clinical pathology diagnosis is a core component of standardized resident training. The electronic pathology reading library has been well-received and recognized by resident doctors. However, further efforts are needed to explore diverse teaching methods that align with modern educational approaches, ultimately contributing to the development of highly skilled resident doctors.

  • Open Access

    Peiminine Alleviates Breast Carcinoma via Reprogramming the PI3K/Akt/mTOR Pathway in vitro and in vivo

    by Wenming Zhao, Jirui Sun, Binjuan Zhou, Haizhi Qiao, Jinmei Li, Shuangqiu Ma, Jinku Zhang

    Background The breast cancer is most frequently diagnosed cancer in the women worldwide. Our study investigated the anticancer effect of peiminine, an alkaloid obtained from Fritillaria thunbergii, against breast carcinoma. Materials and Methods The toxicity study investigated LD50 and the subsequent doses of peiminine for carcinogenic study. The in vitro chemotherapeutic assessment was performed on MCF7 cells through MTT assay and flow cytometry. The breast cancer was developed in rats via induction of DMBA (5 mg/kg, i.v.) and sustained for 24 weeks. The induction of breast cancer and the chemotherapeutic effect of peiminine were assessed through histopathological analysis of rat mammary tissue, followed by immunohistochemical analysis, cell proliferation assay and apoptosis assay by TUNEL method. Results The IC50 value of peiminine in MCF7 cell was found to be 5 μg/mL which demonstrate a significant induction of apoptosis and enhanced caspase-3 expression in MCF7 cells in a dose dependent manner. The complex also caused cell cycle arrest at S phase and G2/M phase dose dependently. Additionally, peiminine therapy decreased the hyperplastic lesions of mammary tissue and restored the normal histopathological characteristics of breast tissue. Furthermore, peiminine treatment downregulated the expression of carcinogenic markers such as PI3K and Akt increased the expression of apoptotic markers including p53 and Bax. Peiminine therapy also decreased the cellular proliferation and enhanced the apoptotic events. Conclusion In conclusion, the breast cancer progression was significantly reduced via induction of apoptotic events and inhibition of cell propagation which allowed constructing of suitable mechanism for peiminine mediated chemotherapeutic approach.


  • Open Access

    Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance

    by Si Lu, Rongjie Zhao, Yicheng Han, Shengpeng Shao, Yaming Ji, Jinku Zhang, Hongming Pan, Jiachun Sun, Yuxiong Feng

    Resistance to immunotherapy poses a significant challenge in the treatment of colorectal cancer (CRC), and the underlying mechanisms are not fully understood. Recent studies have implicated PFKFB3, a crucial glycolytic enzyme, in shaping the tumor microenvironment in CRC. Our study aimed to systematically study the role of PFKFB3 in CRC. Bioinformatic analysis revealed that PFKFB3 expression is notably elevated in CRC tissues compared to normal counterparts. In vivo experiments confirmed that suppressing PFKFB3 reduces the tumorigenesis of CRC. We identified multiple cancer-associated pathways positively correlated with high expression of PFKFB3, such as epithelial-mesenchymal transition (EMT), hypoxia, KRAS signaling, angiogenesis, PI3K/AKT/mTOR, Hedgehog, and Notch pathways. Additionally, PFKFB3 exhibited significant correlations with various immune-related pathways, including complement, IL-2/STAT5, IL-6/JAK/STAT3, IFN-α/IFN-γ, TGF-β, and TNF-α/NF-κB, as well as several immunosuppressive cell markers found in regulatory T cells (CCR8, TGFB1, STAT5B, FOXP3), M2 macrophages (CD163, VSIG4, MS4A4A), T cell exhaustion markers (CTLA-4, PDCD1, LAG3), and PD-L1. Intriguingly, increased PFKFB3 expression was observed in PD-L1 blockade-resistant patients and was associated with shorter overall survival. In a nutshell, PFKFB3 plays an important role in CRC tumorigenesis and resistance to immunotherapy. Targeting PFKFB3 inhibits tumor formation and enhances the efficacy of immunotherapy. Our findings underscore the functions of PFKFB3 in CRC, shedding light on both cancer-related and immunosuppressive pathways.


  • Open Access

    Analysis of the Clinical Value of Immunohistochemical Testing in the Pathological Diagnosis of Breast Cancer

    by Qiushuang Ma, Jirui Sun, Haizhi Qiao, Xueli Wang, Jinku Zhang

    Objective: To investigate the clinical value of immunohistochemistry (IHC) detection in the pathological diagnosis of breast cancer. Methods: Eighty breast cancer patients admitted to Baoding No. 1 Central Hospital from June 2022 to June 2023 were selected as study subjects. The samples were divided into a positive group (40 cases) and a negative group (40 cases) according to ER and PR test results. Immunohistochemistry was performed on all patients to compare the differences between the two groups in C-erbB-2 positive expression and axillary lymph node metastasis. Results: The positive expression rate of C-erbB-2 in the positive group (35.00%) was significantly lower than that in the negative group (80.00%), with a highly significant difference (P < 0.001). The axillary lymph node metastasis rate in the positive group (40.00%) was significantly lower than that in the negative group (75.00%), with a significant difference (P < 0.05). Conclusion: Immunohistochemical detection in breast cancer pathology enhances diagnostic accuracy, predicts prognosis, and supports personalized treatment by identifying ER, PR, and C-erbB-2. It is worth being widely adopted in clinical practice.

  • Open Access

    Detection and Clinical Significance of Peripheral Blood CTC, CA125, CA153, and CEA Levels in Patients with Ductal Carcinoma in situ

    by Jirui Sun, Qiushuang Ma, Hong Chen, Xing Zhou, Jinku Zhang

    Objective: To explore the detection and clinical significance of peripheral blood CTC, CA125, CA153, and CEA levels in patients with DCIS. Methods: 210 patients who received surgical treatment for breast cancer in our hospital from January 2019 to December 2022 were selected as the research subjects. According to the postoperative pathology, 100 cases were divided into breast cancer and 110 benign breast tumor groups. One hundred ten healthy patients undergoing physical examination during the same period were selected as the control group. CA153, CA125, and CEA levels were observed in the three groups. Results: The levels of CA153, CA125, and CEA in the breast cancer group were significantly higher than those in the benign breast tumor group and the control group (P < 0.05); the levels of CA153, CA125, and CEA in the benign breast tumor group were all higher than those in the control group, but the differences were not statistically significant; among the three tumor markers, CA153 has the highest sensitivity at 39.00%, CA125 has the second highest sensitivity at 18.00%, and CEA has the lowest sensitivity at 17.00%; The sensitivity of the two joint tests of CA153+CA125, CA153+CEA, and CA125+CEA for the diagnosis of breast cancer were 50.00%, 48.00%, and 26.00% respectively; the sensitivity of the three joint tests is the highest, reaching 53.00%, while the specificity of the joint tests was lower than the individual tests. Conclusion: Detection of peripheral blood CTC, CA125, CA153, and CEA levels has specific reference significance for the treatment and prognosis of DCIS patients.


  • Open Access

    A negative feedback loop between KLF9 and the EMT program dictates metastasis of hepatocellular carcinoma

    by Tao Wang, Limin Feng, Zhong Shi, Lixian Yang, Xiaofu Yu, Jinsong Wu, Jirui Sun, Jinku Zhang, Yuxiong Feng, Weilin Wang

    Metastasis is the primary cause of death of hepatocellular carcinoma (HCC), while the mechanism underlying this severe disease remains largely unclear. The Kruppel‐like factor (KLF) family is one of the largest transcription factor families that control multiple physiologic and pathologic processes by governing the cellular transcriptome. To identify metastatic regulators of HCC, we conducted gene expression profiling on the MHCC97 cell series, a set of subclones of the original MHCC97 that was established by in vivo metastasis selection therefore harbouring differential metastatic capacities. We found that the expression of KLF9, a member of the KLF family, was dramatically repressed in the metastatic progeny clone of the MHCC97 cells. Functional studies revealed overexpression of KLF9 suppressed HCC migration in vitro and metastasis in vivo, while knockdown of KLF9 was sufficient to promote cell migration and metastasis accordingly. Mechanistically, we found the expression of KLF9 can reverse the pro‐metastatic epithelial‐mesenchymal transition (EMT) program via direct binding to the promoter regions of essential mesenchymal genes, thus repressing their expression. Interestingly, we further revealed that KLF9 was, in turn, directly suppressed by a mesenchymal transcription factor Slug, suggesting an intriguing negative feedback loop between KLF9 and the EMT program. Using clinical samples, we found that KLF9 was not only downregulated in HCC tissue compared to its normal counterparts but also further reduced in the HCC samples of whom had developed metastatic lesions. Together, we established a critical transcription factor that represses HCC metastasis, which is clinically and mechanically significant in HCC therapies.


  • Open Access

    Functionalization of curcumin nanomedicines: a recent promising adaptation to maximize pharmacokinetic profile, specific cell internalization and anticancer efficacy against breast cancer

    by Jinku Zhang, Jirui Sun, Chong Li, Haizhi Qiao, Zahid Hussain

    Owing to its diverse heterogeneity, aggressive nature, enormous metastatic potential, and high remission rate, the breast cancer (BC) is among the most prevalent types of cancer associated with high mortality. Curcumin (Cur) is a potent phytoconstituent that has gained remarkable recognition due to exceptional biomedical viability against a wide range of ailments including the BC. Despite exhibiting a strong anticancer potential, the clinical translation of Cur is restricted due to intrinsic physicochemical properties such as low aqueous solubility, chemical instability, low bioavailability, and short plasma half-life. To overcome these shortcomings, nanotechnology-aided developments have been extensively deployed. The implication of nanotechnology has pointedly improved the physicochemical properties, pharmacokinetic profile, cell internalization, and anticancer efficacy of Cur; however, majority of Cur-nanomedicines are still facing grandeur challenges. The advent of various functionalization strategies such as PEGylation, surface decoration with different moieties, stimuli-responsiveness (i.e., pH, light, temperature, heat, etc.), tethering of specific targeting ligand(s) based on the biochemical targets (e.g., folic acid receptors, transferrin receptors, CD44, etc.), and multifunctionalization (multiple functionalities) has revolutionized the fate of Cur-nanomedicines. This study ponders the biomedical significance of various Cur-nanomedicines and adaptable functionalizations for amplifying the physicochemical properties, cytotoxicity via induction of apoptosis, cell internalization, bioavailability, passive and active targeting to the tumor microenvironment (TME), and anticancer efficacy of the Cur while reversing the multidrug resistance (MDR) and reoccurrence in BC. Nevertheless, the therapeutic outcomes of Cur-nanomedicines against the BC have been remarkably improved after adaptation of various functionalizations; however, this evolving strategy still demands extensive research for scalable clinical translation.Graphical Abstract


  • Open Access

    Application Experience of Quality Feedback in Standardized Practical Skills Training for Clinicopathology Residents

    by Qiushuang Ma, Bingjuan Zhou, Jirui Sun, Wenming Zhao, Jinmei Li, Haizhi Qiao, Jinku Zhang

    In recent years, there are increasingly more standardized trainings for doctors based on the standardized training outline that is suitable for different grades. Hierarchical training has gradually formed a relatively sound training mode. In reflecting students’ learning effect, there is a need for an ideal quality feedback system in the standardized practical skills training for clinical pathology residents. This feedback system can help students achieve the training objectives through understanding and grasping the learning content.

  • Open Access

    Application of organometallic chemistry in the formulation of a modern therapeutic drug by Ag nanoparticles green-mediated by Allium to treat the breast cancer

    by Jinku Zhang, Jirui Sun, Huijuan Geng, Qiushuang Ma, Chong Li

    In the recent study, we decided to survey the capacities of metallic nanoparticles formulated by Allium monanthum (AgNPs) as a novel chemotherapeutic drug in the treatment of several types of breast cancers. Characterization of AgNPs was done by UV–Visible Spectroscopy (UV–Vis), Fourier Transformed Infrared Spectroscopy (FT‐IR), Transmission Electron Microscopy (TEM), and Field Emission Scanning Electron Microscopy (FE‐SEM). For investigating the antioxidant properties of AgNO3, Allium monanthum, and AgNPs, the DPPH test was used in the presence of butylated hydroxytoluene as the positive control. To survey the cytotoxicity and anti-breast cancer effects of AgNO3, Allium monanthum, and AgNPs, MTT assay was used on the breast adenocarcinoma (MCF7), breast carcinoma (Hs 578Bst), infiltrating ductal cell carcinoma (Hs 319.T), infiltrating lobular carcinoma of breast (UACC-3133), inflammatory carcinoma of the breast (UACC-732), and metastatic carcinoma (MDA-MB-453) cell lines. DPPH test revealed similar antioxidant potentials for Allium monanthum, AgNPs, and butylated hydroxytoluene. Silver nanoparticles had very low cell viability and anti-breast cancer properties dose-dependently against MCF7, Hs 578Bst, Hs 319.T, UACC-3133, UACC-732, and MDA-MB-453 cell lines without any cytotoxicity on the normal cell line. The best result of anti-breast cancer properties of AgNPs against the above cell lines was seen in the case of the UACC-3133 cell line. According to the above findings, the silver nanoparticles containing Allium monanthum aqueous extract can be administrated in humans for the treatment of several types of breast cancer especially breast adenocarcinoma, breast carcinoma, infiltrating ductal cell carcinoma, infiltrating lobular carcinoma of breast, inflammatory carcinoma of the breast, and metastatic carcinoma.